发明名称 Macrolides
摘要 The composition of formula Iwherein the substituents have various significances, whereby one of R2 to R4 is ethyl. They can be prepared by fermentation, or by replacement of hydroxy with chloro under simultaneous or concomitant epimerization. They are indicated for use as pharmaceuticals in the prevention or treatment of inflammatory conditions and of conditions requiring immunosuppression, optionally in combination or association with further pharmaceutically active and compatible agents, e.g. macrolactam macrolides such as pimecrolimus.
申请公布号 US6706727(B1) 申请公布日期 2004.03.16
申请号 US20020276622 申请日期 2002.11.18
申请人 NOVARTIS AG 发明人 FLEISSNER GERHARD;HAECKER HELMUT;KUESTERS ERNST;PENN GERHARD
分类号 C12P17/16;A61K31/395;A61P1/04;A61P3/10;A61P5/14;A61P11/06;A61P17/06;A61P17/14;A61P21/04;A61P25/28;A61P27/02;A61P27/16;A61P29/00;A61P37/02;A61P37/06;A61P37/08;C07D498/18;(IPC1-7):C07D498/18;A61K31/436 主分类号 C12P17/16
代理机构 代理人
主权项
地址